During the last three months, 6 analysts shared their evaluations of Valneva VALN, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of their recent ...

Shares of VALN stock opened at $7.17 on Friday. Valneva has a 1 year low of $3.62 and a 1 year high of $9.50. The firm’s fifty day simple moving average is $6.34 and its 200 day simple moving ...

Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is ...

Saint Herblain (France), March 24, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly ...

CEO Thomas Lingelbach highlighted that Valneva achieved double-digit year-on-year sales growth, with total product sales surpassing €160 million for 2024, in line with guidance. The company ...

In a report released on March 20, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a price target of €8.10. The company’s shares closed ...

The latest price target for Valneva (NASDAQ:VALN) was reported by HC Wainwright & Co. on March 21, 2025. The analyst firm set a price target for $17.00 expecting VALN to rise to within 12 months ...

New data for Valneva and Pfizer's experimental vaccine for Lyme disease – the furthest ahead in clinical testing – have bolstered the case for the shot as the results of a phase 3 programme ...